Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BA vs MRNA✓SelectedUSD · MRNABA vs MRNA performance historyLatest closeAs of-2.88%11/20
Stock and ETF performance explorer

BA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-50.4%
MRNA return
+786.4%
Excess return
-836.7%
Maximum drawdown
-77.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.9%-2.2%-0.7%-2.8%
7D-9.1%-12.7%+3.6%-8.6%
30D-18.9%-20.7%+1.7%-18.3%
3M-27.5%+46.3%-73.8%-28.8%
6M-29.8%+305.2%-335.1%-36.4%
YTD-28.2%+561.2%-589.4%-37.2%
1Y-13.1%+772.1%-785.2%-25.3%
3Y-28.4%+147.0%-175.4%-35.1%
5Y-27.2%-26.1%-1.1%-33.3%
All-50.4%+786.4%-836.7%-53.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling